COVID Vaccine Policy Updates

Order byBest matchMost fresh

Covid-19, FDA and Vaccine

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine access, and medical ethics.

· 1d · on MSN

· 2d

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

· 2d · on MSN

FDA Updates COVID-19 Vaccine Regulations—Here’s What to Know

Uncertainty loomed as FDA advisors met to discuss this year’s COVID shot

Expert advisors for the Food and Drug Administration met Thursday to discuss which virus strain this year's updated COVID-19 vaccines should target.

· 1d

Arizona PBS · 1d

FDA ends routine COVID shots for healthy young Americans

STAT · 1d

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

3don MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

2don MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter

4don MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

McKnight's Long-Term Care News2d

Therapy firm to pay in COVID vaccine religious-discrimination case

A rehab firm will pay a cash settlement to an occupational therapist it fired when the worker declined a COVID-19 vaccination.

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.